ArticleJournal of racial and ethnic health disparities2026
Race is a Contributing Factor to Clinico-Pathological Characteristics of Ameloblastoma at a Multi-Network Academic Hospital System.
Article in Journal of racial and ethnic health disparities, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Ameloblastoma is an odontogenic tumor with an aggressive growth pattern and high recurrence rate. Impact of race and geographic location on clinico-pathological characteristics of ameloblastoma is unclear. The study objective was to assess race-dependent clinico-pathological characteristics and treatment approaches for ameloblastoma at a hospital network of an academic institution located in a racially diverse metropolitan city. Retrospective analysis of ameloblastoma patient records spanning 15 years from 2009 to 2024 was performed. Data extracted included patient demographic profile, clinical, radiologic, histologic, and treatment information. Data analysis assessed the association between race, clinical, histological, and radiological features of ameloblastoma, as well as treatment approaches. Median age of a total of 64 ameloblastoma patients was 44 years. African American patients were significantly younger, under 21 years of age, than non-African American patients (p = 0.004). Mandible, especially posterior region, was the most affected anatomic site (78.1%). Conventional ameloblastoma (72.3%) was the most common histologic type, but unicystic ameloblastoma was the most common in young individuals (p = 0.004) and African Americans. Jaw resection with reconstruction was the primary modality of treatment (75.4%), especially for conventional type, while most unicystic lesions were treated by enucleation and curettage. Ameloblastoma tumor volume was relatively larger in the following groups: males, African Americans, young patients, conventional histologic type, and unilocular radiographic lesions, which directly guided the decision to treat by surgical resection (p = 0.0001). There were no significant racial differences in presentation-time-to-treatment. Ameloblastoma developed at a young age, grew faster and larger in African American patients. Presentation-time-to-treatment and management approaches were not influenced by race.
Indexed as
Identifiers
41505066What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.